NSUN2 and squamous cell carcinoma: The m5C writer NSUN2 was demonstrated to enhance the progression of squamous cell carcinoma by stabilizing LIN28B-dependent GRB2, which could activate the AKT and RTK signaling pathways (Su et al., 2021).